0LO3 Stock Chart & Stats
$203.84
$0.69(0.34%)
At close: 4:00 PM EDT
$203.84
$0.69(0.34%)
Day’s Range― - ―
52-Week Range$148.70 - $310.50
Previous CloseN/A
Volume53.00
Average Volume (3M)1.71K
Market Cap
$44.80B
Enterprise Value$26.54K
Total Cash (Recent Filing)$7.24B
Total Debt (Recent Filing)$151.69M
Price to Earnings (P/E)44.6
Beta0.65
Next Earnings
Nov 26, 2026EPS Estimate
2.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.21
Shares Outstanding161,908,840
10 Day Avg. Volume1,427
30 Day Avg. Volume1,710
Financial Highlights & Ratios
PEG Ratio1.42
Price to Book (P/B)4.63
Price to Sales (P/S)10.44
P/FCF Ratio24.08
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$293.10Price Target Upside43.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering23
EPS Forecast (FY)9.07
Revenue Forecast (FY)$3.65B
Bulls Say, Bears Say
Bulls Say
High-margin ProfitabilityVeeva’s high gross, operating, and net margins indicate strong software economics and pricing power. Because its subscription platform serves regulated life sciences workflows, these margins can remain durable as customers expand usage across applications.
Conservative Balance Sheet And Cash GenerationMinimal leverage gives Veeva substantial financial flexibility to fund product development, customer implementation, and selective investments without dependence on external capital. Strong cash conversion also supports resilience through slower growth or changing industry conditions.
Platform Expansion And Customer AdoptionGrowth across Commercial Cloud, Data Cloud, and CRM shows customers are adopting a broader portion of Veeva’s life sciences platform. Increasing product breadth can deepen switching costs, expand account revenue, and reinforce Veeva’s specialized market position.
Bears Say
Material Revenue Growth DecelerationThe sharp slowdown suggests Veeva is entering a more mature phase, making sustained rapid expansion harder to achieve. Slower top-line growth could limit operating leverage, reduce the pace of customer acquisition benefits, and increase reliance on newer products.
Recent Free Cash Flow ContractionAlthough cash generation remains strong, the recent decline warrants monitoring because it may reflect timing, investment, or slower earnings momentum. Persistent deterioration would reduce funds available for innovation and make the company’s otherwise strong earnings conversion less durable.
AI Monetization And Execution RiskFalcon and Aspen could broaden Veeva’s platform, but early product readiness, onboarding limits, uncertain pricing, and compute expense create execution risk. If adoption scales before economics improve, AI investment could delay revenue realization or dilute otherwise strong margins.
Veeva Systems News
0LO3 FAQ
What was Veeva Systems’s price range in the past 12 months?
Veeva Systems lowest share price was $148.70 and its highest was $310.50 in the past 12 months.
What is Veeva Systems’s market cap?
Veeva Systems’s market cap is $44.80B.
When is Veeva Systems’s upcoming earnings report date?
Veeva Systems’s upcoming earnings report date is Nov 26, 2026 which is in 88 days.
How were Veeva Systems’s earnings last quarter?
Veeva Systems released its earnings results on Aug 26, 2026. The company reported $2.35 earnings per share for the quarter, beating the consensus estimate of $2.228 by $0.122.
Is Veeva Systems overvalued?
According to Wall Street analysts Veeva Systems’s price is currently Undervalued.
Does Veeva Systems pay dividends?
Veeva Systems does not currently pay dividends.
What is Veeva Systems’s EPS estimate?
Veeva Systems’s EPS estimate is 2.34.
How many shares outstanding does Veeva Systems have?
Veeva Systems has 161,908,840 shares outstanding.
What happened to Veeva Systems’s price movement after its last earnings report?
Veeva Systems reported an EPS of $2.35 in its last earnings report, beating expectations of $2.228. Following the earnings report the stock price went up 15.493%.
Which hedge fund is a major shareholder of Veeva Systems?
Currently, no hedge funds are holding shares in GB:0LO3
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Veeva Systems Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$293.10 (43.79% Upside)
$293.10 (43.79% Upside)
Blogger Sentiment
Bullish
GB:0LO3 Sentiment 81%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-36.05%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
17.57%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Veeva Systems
Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functions—encompassing sales, marketing, and medical content and communications—and comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on data migration and systems integrations, comprehensive training programs, and ongoing managed services such as outsourced systems administration. Tracing its origins, the company was incorporated in 2007 as Verticals onDemand, Inc., and subsequently rebranded to Veeva Systems Inc. in April 2009. Its corporate headquarters are situated in Pleasanton, California.
0LO3 Company Deck
0LO3 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated a predominantly positive operational and financial performance: revenue of $928M, non-GAAP operating income of $416M (~44.8% margin), strong commercial subscription growth (~13% YoY), record CRM results, and meaningful early traction in AI (Falcon) and Data Cloud. Management raised guidance and highlighted selective, disciplined investments (Aspen) and a healthy IQVIA partnership. Key risks centered on execution and timing for agentic AI (product readiness, onboarding capacity, pricing models), potential model-compute cost pressure, and staggered timing of R&D product ramps. Overall, highlights (strong revenue/profitability, CRM wins, AI interest, Data Cloud additions, guidance raise) materially outweigh the manageable near-term execution and timing lowlights.View all GB:0LO3 earnings summaries0LO3 Revenue Breakdown
58.18% North America
27.79% Europe
11.35% APAC
2.68% Middle East, Africa, and Latin America
0LO3 Stock 12 Month Forecast
Average Price Target
$293.10
▲(43.79% Upside)